OTCQB:CELZ - OTCQB:GNBT - OTCQB:IMNP - OTCQB:SGMD - OTCQB:SPLIF - OTCQX:IGXT - OTCQX:SNNVF - PINK:SWRM - 24/7 Market News

Venture Breakfast Bits, by 24/7 Market News

2018-10-17T10:23:16+00:00 Oct. 17, 2018 10:21AM EST|

Venture Market News for October 17, 2018

  • IntelGenx Receives Over $1.6 Million from Exercise of Warrants

SAINT LAURENT, Quebec, Oct. 17, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce that, since September 15, 2018, it has received proceeds of US$1,634,294 as a result of the exercise of 2,894,606 previously issued common share purchase warrants (the “Warrants”).

Full press release

  • Sugarmade Signs LOI to Acquire Major Hydroponic Supplier, Raises FY2019 Sales Outlook to $70M

MONROVIA, California, October 17, 2018 /PRNewswire/ --Sugarmade, Inc. (OTCQB: SGMD), one of the largest publicly traded hydroponics supply companies, today announces the signing of a binding Letter of Intent ("LOI") to acquire Sky Unlimited, LLC, dba Athena United (www.AthenaUnited.com), a California-based supplier of cannabis cultivation materials to wholesalers and large commercial cannabis cultivators. Sugarmade expects this acquisition to be highly accretive to earnings and shareholder value and thus is revising its guidance for full-year 2019 revenues to more than $70 million.

Full press release

  • Shareholder Update: Creative Medical Technology Holdings, Inc.

PHOENIX, Oct. 17, 2018 /PRNewswire/ -- (OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its activities:

Full press release

  • Immune Pharmaceuticals Announces Positive Preclinical Results in Asthma

A broad anti-inflammatory effect observed

FORT LEE, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, announced today positive results from a mouse study demonstrating that blockade of eotaxin-1 reduces lung inflammation and has a broader inhibitory effect on inflammatory cells than does blockade of interleukin (IL)-5.

Full press release

  • Sunniva to Acquire Northern California Licensed Cultivation and Genetics Facility

VANCOUVER, B.C., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Sunniva Inc. (“Sunniva” or the “Company“) (CSE:SNN) (OTCQX:SNNVF), a North American provider of cannabis products and services, is pleased to announce that the Company has signed a non-arms length binding letter of intent dated October 16, 2018 with the Oakland Vision Project (“Vision”) to acquire all the issued and outstanding equity interests of the companies that comprise Vision (the “LOI”).  Vision is co-owned by Vinayak Shastry, Sunniva’s President of US Operations.  Vision operates a licensed cultivation facility located in Irvine, California (the “Vision Facility”).   Completion of the acquisition remains subject to a number of conditions including, among other things: the negotiation and execution of a definitive agreement between Sunniva and Vision, completion of due diligence and receipt of regulatory approvals, including approval of the Canadian Securities Exchange (“CSE”).

Full press release

  • AppSwarm Inc., Signs Co-Marketing Deal with Algae World, Inc., a Subsidiary of KYN Capital and Algae World Projects Its Revenues to Surpass Five Million Through Second Quarter 2019 for All Its Companies

TULSA, OK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AppSwarm, Inc. (OTC: SWRM) and KYN Capital Group Inc. (OTC: KYNC) announced that they signed a co-marketing agreement to market each other’s products. Algae World Inc., a Los Angeles headquartered algae production company, which owns several subsidiaries now projects that its revenues will surpass five million dollars through the first half of 2019 (http://www.algaeworld.info). Further, they anticipate their Co-Marketing Agreement with AppSwarm Inc., will help add to the Bottom Line.

Full press release

  • Generex Announces Launch of NuGenerex Distribution Solutions

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce the launch of NuGenerex Distribution Solutions, and the commencement of business operations enabled through the acquisition of certain operating assets of Veneto Holdings, L.L.C., as announced on October 9, 2018.

Full press release

  • Nutritional High and Aura Health Announce Partnership to Develop International Markets

TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. ("Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) and Aura Health Inc. (“Aura”) (CSE: BUZZ) are pleased to announce the development of a framework to bring Nutritional High’s extraction and edibles technology and products to European and Israeli markets.

Full press release

Connect with 24/7 Market News on social media

https://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com 

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements

CONTACT:

24/7 Market News

Editor@247marketnews.com

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/